MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.41 -0.06 (-0.52%)
At close: Oct 2, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Cash & Current Investments (2020 - 2026)

Updated

MoonLake Immunotherapeutics (MLTX) recorded Cash & Current Investments of $537.03 million in Q2 2026, up 26.3% from $425.08 million a year earlier and up 50.0% from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, MoonLake Immunotherapeutics reported Cash & Current Investments of $393.97 million, down 12.1% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 211.8% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $448.03 million in FY2024 (-12.3%), $511.01 million in FY2023 (+608.6%), $72.11 million in FY2022 (+797.1%) and $8.04 million in FY2021 (+501.7%).
  • The Q2 2026 figure is the highest quarterly Cash & Current Investments since Q1 2024.
  • On a year-over-year basis, Cash & Current Investments rose in 1 of the last eight quarters, with an average decline of 9.7%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 797.1% in Q4 2022, against a decline of 98.0% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $357.92 million (Q1 2026), $393.97 million (Q4 2025) and $380.48 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 MoonLake Immunotherapeutics 971.07 Mn -698.33 Mn - 537.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 537.03 Mn
Mar 31, 2026 357.92 Mn
Dec 31, 2025 393.97 Mn
Sep 30, 2025 380.48 Mn
Jun 30, 2025 425.08 Mn
Mar 31, 2025 480.13 Mn
Dec 31, 2024 448.03 Mn
Sep 30, 2024 493.92 Mn
Jun 30, 2024 519.80 Mn
Mar 31, 2024 547.05 Mn
Dec 31, 2023 511.01 Mn
Sep 30, 2023 495.98 Mn
Jun 30, 2023 501.79 Mn
Mar 31, 2023 63.05 Mn
Dec 31, 2022 72.11 Mn
Sep 30, 2022 83.50 Mn
Mar 31, 2022 23,336.00
Dec 31, 2021 8.04 Mn
Sep 30, 2021 1.03 Mn
Jun 30, 2021 1.10 Mn
API Access

MoonLake Immunotherapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MLTX&period=max&api_key=YOUR_API_KEY